reduced results from

147 billion

123 million

2 million

12285

to ~147 options

options split into images, definition, symptoms, related diagnoses, diagnostic tests, therapies, and medications

what is 'imatinib mesylate'? Definition for Imatinib mesylate Imatinib is a drug used to treat certain types of cancer . It is currently marketed by Novartis as Gleevec ( USA ) or Glivec ( Europe / Australia ) as its mesylate salt, imatinib mesilate ( INN ). more Imatinib is a drug used to treat certain types of cancer . It is currently marketed by Novartis as Gleevec ( USA ) or Glivec ( Europe / Australia ) as its mesylate salt, imatinib mesilate ( INN ). It was originally coded during development as CGP57148B or STI-571 (these terms are used in early preclinical publications). It is used in treating chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs) and a number of other malignancies . less diagnoses treated with 'imatinib mesylate' 1 - 3 of 3 diagnosis small intestine carcinoma small bowel cancer web search for: Imatinib mesylate and small intestine carcinoma acute lymphocytic leukemia cancer of white blood cells web search for: Imatinib mesylate and acute lymphocytic leukemia myelofibrosis scarred bone marrow web search for: Imatinib mesylate and myelofibrosis related procedures when taking 'imatinib mesylate' 1 - 5 of 105 procedures Abdominal CAT Scan web search for: Imatinib mesylate and Abdominal CAT Scan Blood, Platelet Count Platelet Count web search for: Imatinib mesylate and Blood, Platelet Count Complete Blood Count web search for: Imatinib mesylate and Complete Blood Count Biopsy web search for: Imatinib mesylate and Biopsy Biopsy small bowel web search for: Imatinib mesylate and Biopsy small bowel Capsule endoscopy web search for: Imatinib mesylate and Capsule endoscopy Carcinoembryonic Antigen (CEA) web search for: Imatinib mesylate and Carcinoembryonic Antigen (CEA) Colonoscopy Colonoscopy web search for: Imatinib mesylate and Colonoscopy Colonoscopy with retrograde ileoscopy web search for: Imatinib mesylate and Colonoscopy with retrograde ileoscopy Double-contrast barium enema web search for: Imatinib mesylate and Double-contrast barium enema Endoscopic ultrasonography Endoscopic Ultrasound web search for: Imatinib mesylate and Endoscopic ultrasonography Endoscopy web search for: Imatinib mesylate and Endoscopy Endoscopy, Upper Gastrointestinal Endoscopy web search for: Imatinib mesylate and Endoscopy, Upper Gastrointestinal Enteroclysis web search for: Imatinib mesylate and Enteroclysis KUB web search for: Imatinib mesylate and KUB Liver Function Tests elevated liver enzymes web search for: Imatinib mesylate and Liver Function Tests Pancreaticoduodenectomy (Whipple procedure) web search for: Imatinib mesylate and Pancreaticoduodenectomy (Whipple procedure) Partial Resection of Intestine with Anastomosis web search for: Imatinib mesylate and Partial Resection of Intestine with Anastomosis Pill camera web search for: Imatinib mesylate and Pill camera Resection web search for: Imatinib mesylate and Resection for more please login, login is free (click to login) related medication for 'imatinib mesylate' 1 - 5 of 39 drugs fluorouracil web search for: Imatinib mesylate and fluorouracil irinotecan web search for: Imatinib mesylate and irinotecan leucovorin web search for: Imatinib mesylate and leucovorin oxaliplatin web search for: Imatinib mesylate and oxaliplatin sunitinib web search for: Imatinib mesylate and sunitinib prednisone web search for: Imatinib mesylate and prednisone 6-mercaptopurine (6-mp), epipodophyllotoxins web search for: Imatinib mesylate and 6-mercaptopurine (6-mp), epipodophyllotoxins allopurinol web search for: Imatinib mesylate and allopurinol anthracycline web search for: Imatinib mesylate and anthracycline asparaginase web search for: Imatinib mesylate and asparaginase asparaginase(elspar ) web search for: Imatinib mesylate and asparaginase(elspar ) clofarabine web search for: Imatinib mesylate and clofarabine clotrimazole troches web search for: Imatinib mesylate and clotrimazole troches cyclophosphamide(cytoxan) web search for: Imatinib mesylate and cyclophosphamide(cytoxan) cytarabine web search for: Imatinib mesylate and cytarabine cytarabine(cytosar-u , tarabine pfs) web search for: Imatinib mesylate and cytarabine(cytosar-u , tarabine pfs) dasatinib(sprycel ) web search for: Imatinib mesylate and dasatinib(sprycel ) daunorubicin web search for: Imatinib mesylate and daunorubicin daunorubicin(cerubidine , daunorubicin hydrochloride) web search for: Imatinib mesylate and daunorubicin(cerubidine , daunorubicin hydrochloride) dexamethasone web search for: Imatinib mesylate and dexamethasone for more please login, login is free (click to login) The following are types of physicians relevant for 'Imatinib mesylate'. related types of physicians 'family practitioner, internist, oncologist' show local physicians postal code Find Local stars represent relevance to topic not rating more The results are computer generated suggestions to help you find a physician. MEDgle does not recommend any particular type of physician or claim to be complete or accurate in the providers and specialties suggested. web search results for 'imatinib mesylate'? Results 1 - 50 - Imatinib mesylate Imatinib - Wikipedia, the free encyclopedia One study demonstrated that Imatinib mesylate was effective in patients with ... Imatinib mesylate in the treatment of systemic mastocytosis: a phase II trial. ... http://en.wikipedia.org/wiki/Imatinib_mesylate   en.wikipedia.org - summary Gleevec (Imatinib Mesylate) Drug Information: Uses, Side Effects, Drug ... Learn about the prescription medication Gleevec (Imatinib Mesylate), drug uses, dosage, side effects, drug interactions, warnings, and patient labeling. http://www.rxlist.com/cgi/generic3/gleevec.htm   www.rxlist.com - summary Imatinib mesylate Drug details for Imatinib mesylate. ... myeloid leukemia treated with imatinib mesylate. ... Cardiotoxicity of the cancer therapeutic agent imatinib mesylate. ... http://www.webmd.com/cancer/imatinib-mesylate   www.webmd.com - summary Imatinib Mesylate Drug Information, Professional Imatinib Mesylate Drug Information from Drugs.com. Includes Imatinib Mesylate side effects, interactions and indications. ... IMATINIB MESYLATE CAPSULES ... http://www.drugs.com/mmx/imatinib-mesylate.html   www.drugs.com - summary Imatinib mesylate - Yahoo! Health Imatinib is available as capsules you ... with chronic myeloid leukemia treated with imatinib mesylate. ... of the cancer therapeutic agent imatinib mesylate. ... http://health.yahoo.com/other-other/imatinib-mesylate/healthwise--tv7950.html   health.yahoo.com - summary Treatment of gastrointestinal stromal tumor: focus on imatinib mesylate Pharmacology of imatinib mesylate. Preclinical studies of imatinib ... as it is one of the targets of the tyrosine kinase inhibitor imatinib mesylate. ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2503651   www.pubmedcentral.nih.gov - summary MedlinePlus Drug Information: Imatinib Imatinib ... Imatinib is used to treat certain types of leukemia (cancer that begins in the ... if you are allergic to imatinib or any other medications. ... http://www.nlm.nih.gov/medlineplus/druginfo/meds/a606018.html   www.nlm.nih.gov - summary Imatinib: Drug Information Provided by Lexi-Comp: Merck Manual Professional ... R, et al, "Adjuvant Imatinib Mesylate Increases Recurrence Free Survival (RFS) ... and Pharmacokinetic Study of Imatinib Mesylate in Patients With Advanced ... http://www.merck.com/mmpe/lexicomp/imatinib.html   www.merck.com - summary Definition of imatinib mesylate - NCI Dictionary of Cancer Terms Report to Nation Finds Declines in ... imatinib mesylate (ih-MAH-tih-nib MEH-zih-layt) ... Imatinib mesylate blocks the protein made by the bcr/abl oncogene. ... http://www.nci.nih.gov/Templates/db_alpha.aspx?CdrID=44893   www.nci.nih.gov - summary Control of aggressive fibromatosis by treatment with imatinib mesylate ... ... the number of kinases blocked by imatinib mesylate is notching up, for instance ... CONCLUSIONS: Treatment with imatinib mesylate has been a well-accepted therapy ... http://www.ncbi.nlm.nih.gov/pubmed/17453242   www.ncbi.nlm.nih.gov - summary IMATINIB - ORAL (Gleevec) side effects, medical uses, and drug interactions. Read more about the prescription drug IMATINIB - ORAL. ... USES: Imatinib is used to treat a type of leukemia (chronic myeloid leukemia or ... http://www.medicinenet.com/imatinib-oral/article.htm   www.medicinenet.com - summary Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib ... Imatinib mesylate (Gleevec, STI571) has become the standard of care for the ... Inhibitor concentrations were as follows: imatinib mesylate, 2 ?M, 4 ?M, 8 ?M, ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pub...   www.pubmedcentral.nih.gov - summary Mesylate - Wikipedia, the free encyclopedia In chemistry, a mesylate is any salt or ester of methanesulfonic acid (C ... spelling is mesilate (as in imatinib mesilate, the mesylate salt of imatinib).[1] ... http://en.wikipedia.org/wiki/Mesylate   en.wikipedia.org - summary Imatinib facts and comparsions at Drugs.com All about Imatinib. View complete and up to date Imatinib information - part of the Drugs.com trusted medication database. ... a dose of Imatinib , take it as ... http://www.drugs.com/cdi/imatinib.html   www.drugs.com - summary Clinical Study: 02-I-0286, A Pilot Study of the Safety and Efficacy of ... Clinical Study Summary Sheet for 02-I-0286 ... Imatinib mesylate will be initiated at a dose of 400 mg daily, the FDA-approved ... http://clinicalstudies.info.nih.gov/detail/A_2002-I-0286.html   clinicalstudies.info.nih.gov - summary Chronic Myelogenous Leukemia Higher doses of imatinib mesylate, alternative tyrosine kinase inhibitors such ... What is the best dose of imatinib mesylate and should it be combined with other ... http://www.webmd.com/cancer/tc/leukemia-chronic-myelogenous-...   www.webmd.com - summary National Biospecimen Network Imatinib mesylate (STI-571, Gleevec®; Novartis, Basel, Switzerland), a small ... Clinical use of imatinib mesylate in patients with GIST proved dramatic, as 60 ... http://prostatenbnpilot.nci.nih.gov/blue_app_b.asp   prostatenbnpilot.nci.nih.gov - summary Imatinib mesylate causes hypopigmentation in the skin. In clinical trials with imatinib mesylate, common side effects of nausea, emesis, ... Imatinib mesylate induced hypopigmentation also appeared to be reversible and ... http://www.ncbi.nlm.nih.gov/pubmed/14635084   www.ncbi.nlm.nih.gov - summary Synergistic interactions between imatinib mesylate and the novel ... ... by which E255K and T315I affect imatinib mesylate's interactions with the ... Conceivably, this mutation affects imatinib mesylate binding by altering the ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1895085   www.pubmedcentral.nih.gov - summary Imatinib mesylate enhances therapeutic effects of gemcitabine in human ... Imatinib mesylate (STI571; Glivec) is a selective inhibitor of tyrosine kinases ... We previously showed that imatinib mesylate synergizes with gemcitabine and ... http://www.ncbi.nlm.nih.gov/pubmed/18223230   www.ncbi.nlm.nih.gov - summary The role of c-kit and imatinib mesylate in uveal melanoma Imatinib mesylate is a FDA approved compound that inhibits tyrosine quinase ... Imatinib mesylate controls tumor growth in up to 85% of advanced ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pub...   www.pubmedcentral.nih.gov - summary Talk:Imatinib - Wikipedia, the free encyclopedia ... move this page to the INN Imatinib mesylate. ... INN is Imatinib mesilate, not mesylate. ... The Novartis documentation refers to it as 'imatinib mesylate' ... http://en.wikipedia.org/wiki/Talk:Imatinib   en.wikipedia.org - summary imatinib - PubChem Public Chemical Database PubChem Compound Summary ... contain imatinib mesylate equivalent to 100mg or 400 mg of imatinib free base. Imatinib mesylate is designated chemically as ... http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5291   pubchem.ncbi.nlm.nih.gov - summary PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic ... Imatinib mesylate is highly effective in newly diagnosed chronic myeloid ... Imatinib mesylate had a complete cytogenetic response rate of 13% to 24% in ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1895078   www.pubmedcentral.nih.gov - summary Imatinib mesylate in the treatment of systemic mastocytosis: a phase II ... Imatinib mesylate is a potent inhibitor of c-kit receptor tyrosine kinase activity. ... In general, imatinib mesylate was tolerated well. ... http://www.ncbi.nlm.nih.gov/pubmed/16779792   www.ncbi.nlm.nih.gov - summary Drug Information for Imatinib Oral - WebMD Find medical information for Imatinib Oral including side effects, drug interactions, images and pictures, medication ... to Imatinib Mesylate Oral. Consumer ... http://www.webmd.com/drugs/drug-20983-Imatinib+Mesylate+Oral...   www.webmd.com - summary Therapeutic options for chronic myeloid leukemia: focus on imatinib ... Imatinib mesylate (Glivec®/Gleevec?) Results in chronic phase CML. Treatment strategies 2007 ... molecule inhibitor imatinib mesylate (Glivec®, Gleevec? ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2503652   www.pubmedcentral.nih.gov - summary Definition of imatinib mesylate - National Cancer Institute Drug Dictionary imatinib mesylate. The mesylate salt of imatinib, a tyrosine kinase inhibitor with antineoplastic ... Imatinib binds to an intracellular pocket located within ... http://www.nci.nih.gov/Templates/drugdictionary.aspx?CdrID=37862   www.nci.nih.gov - summary Hypopigmentation in an African patient treated with imatinib mesylate ... Imatinib mesylate (STI 571, Gleevec) is a potent bcr-abl tyrosine kinase inhibitor. ... in patients receiving imatinib mesylate for CML has been ... http://www.ncbi.nlm.nih.gov/pubmed/12934870?ordinalpos=146&i...   www.ncbi.nlm.nih.gov - summary Population pharmacokinetics of imatinib mesylate in patients with ... Population pharmacokinetics of imatinib mesylate in patients with chronic-phase ... Imatinib mesylate (Gleevec®, Glivec®, formerly STI571; Novartis Pharma AG, Basel, ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1884912   www.pubmedcentral.nih.gov - summary BCR-ABL mRNA levels at and after the time of a complete cytogenetic ... Imatinib mesylate induces a complete hematologic response in approximately 97 ... In patients treated with imatinib mesylate who were resistant or intolerant of ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1895785   www.pubmedcentral.nih.gov - summary cml gleevec prognosis Imatinib mesylate (STI-571, Gleevec) and reduced intensity conditioning stem ... assessing the role of imatinib mesylate and RIC transplantation should be ... http://www.ncbi.nlm.nih.gov/pubmed/15382266   www.ncbi.nlm.nih.gov - summary Activation mutations of human c-KIT resistant to imatinib mesylate are ... Variable sensitivities to PKC412 or imatinib mesylate were observed among other mutants. ... have suggested that imatinib mesylate might be of value ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1895184   www.pubmedcentral.nih.gov - summary Approval summary: imatinib mesylate in the treatment of metastatic and ... PURPOSE: Imatinib mesylate (Gleevec; Novartis, East Hanover, NJ)is a receptor ... CONCLUSIONS: On February 1, 2001, imatinib mesylate was approved by the United ... http://www.ncbi.nlm.nih.gov/pubmed/12374669   www.ncbi.nlm.nih.gov - summary Selective tyrosine kinase inhibition by imatinib mesylate for the ... Cell lines, antibodies, and imatinib mesylate. ... Imatinib mesylate tablets (purchased from Stanford Inpatient Pharmacy Services) ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pub...   www.pubmedcentral.nih.gov - summary gleevec treatment gist ... 6667 63 5 2003 Drugs Imatinib mesylate: in the treatment of gastrointestinal ... One such drug is imatinib mesylate (imatinib, Glivic/Gleevec), an orally ... http://www.ncbi.nlm.nih.gov/pubmed/12600228   www.ncbi.nlm.nih.gov - summary The Merendino procedure following preoperative imatinib mesylate for ... Imatinib mesylate is a selective small molecule receptor inhibitor of tyrosine ... After pre-treatment with imatinib mesylate and relevant tumor shrinkage ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2323006   www.pubmedcentral.nih.gov - summary Relative Hypocalcaemia and Muscle Cramps in Patients Receiving Imatinib ... Imatinib mesylate is a tyrosine kinase inhibitor targeted to BCR-ABL, PDGFR, and ... extensive abdominal GIST commenced imatinib mesylate (Glivec, Novartis) 400 mg ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1557796   www.pubmedcentral.nih.gov - summary Efficacy of imatinib mesylate in the treatment of refractory ... Efficacy of imatinib mesylate in the treatment of refractory ... Imatinib mesylate enables selective, dual inhibition of the transforming growth ... http://www.ncbi.nlm.nih.gov/pubmed/18762765   www.ncbi.nlm.nih.gov - summary Advanced gastrointestinal stromal tumors successfully treated with ... Imatinib mesylate (STI 571,Gleevec) is a selective inhibitor of certain protein ... Imatinib mesylate induced a sustained response in both patients with advanced ... http://www.ncbi.nlm.nih.gov/pubmed/14717479?ordinalpos=96&it...   www.ncbi.nlm.nih.gov - summary Molecular response of gastrointestinal stromal tumour after treatment ... Imatinib mesylate (STI571), a small molecule tyrosine kinase inhibitor, is a ... Imatinib mesylate has changed the treatment of metastatic GISTs completely. ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1770203   www.pubmedcentral.nih.gov - summary Surgery of Residual Disease Following Molecular-targeted Therapy With ... ... were treated with imatinib mesylate at a single ... Casali PG, Fumagalli E, Messina A, et al. Tumor response to imatinib mesylate in advanced GIST. ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1877023   www.pubmedcentral.nih.gov - summary Treatment of Philadelphia chromosome-positive acute lymphocytic ... Imatinib mesylate, an inhibitor of the Bcr-Abl tyrosine kinase, has modest ... Outcome with hyper-CVAD and imatinib mesylate appears better than with prior ... http://www.ncbi.nlm.nih.gov/pubmed/14551133   www.ncbi.nlm.nih.gov - summary Metastatic duodenal GIST: role of surgery combined with imatinib mesylate Imatinib mesylate, a specific tyrosine kinase inhibitor, is one of the first ... Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1851968   www.pubmedcentral.nih.gov - summary Imatinib mesylate dose escalation is associated with durable responses ... Imatinib mesylate dose escalation is associated with durable responses in ... In conclusion, imatinib dose escalation can induce sustained responses in a ... http://www.ncbi.nlm.nih.gov/pubmed/19060245?dopt=abstractplus   www.ncbi.nlm.nih.gov - summary The small molecule tyrosine kinase inhibitor AMN107 inhibits TEL-PDGFR? ... The imatinib mesylate?resistant mutant TEL-PDGFR? T681I was sensitive to AMN107, ... However, clinical resistance to imatinib mesylate is emerging as an important ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pub...   www.pubmedcentral.nih.gov - summary Hematologic and cytogenetic responses to imatinib mesylate in chronic ... ... and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. ... Imatinib mesylate, formerly STI571, is a selective inhibitor of this kinase. ... http://www.ncbi.nlm.nih.gov/pubmed/11870241   www.ncbi.nlm.nih.gov - summary Combined Surgical and Molecular Therapy Imatinib mesylate (STI 571, Gleevec; Novartis Pharmaceuticals, Basel Switzerland) ... Trials of Imatinib Mesylate in Metastatic GIST ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1602162   www.pubmedcentral.nih.gov - summary Imatinib mesylate selectively impairs expansion of memory cytotoxic T ... Imatinib mesylate selectively impairs expansion of memory cytotoxic T cells ... Imatinib mesylate (imatinib) is a potent inhibitor of defined tyrosine kinases ... http://www.ncbi.nlm.nih.gov/pubmed/16873671?ordinalpos=7&ito...   www.ncbi.nlm.nih.gov - summary Large duodenal GIST with massive liver secondaries melting under ... The phenomenon of metastatic GIST responding to Imatinib mesylate is not new. ... Imatinib mesylate, a specific tyrosikine kinase inhibitor has produced a ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2570680   www.pubmedcentral.nih.gov - summary show more 1  2

Chat with eNurse Kim about 'Imatinib mesylate' or something else! quick facts related diagnosis category oncology gastrointestinal hematological